Skytrofa - NDC Database
9 records found
Page:
73362-003 Aug 25, 2021
Skytrofa 3 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
Skytrofa 3 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
73362-004 Aug 25, 2021
Skytrofa 3.6 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
Skytrofa 3.6 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
73362-005 Aug 25, 2021
Skytrofa 4.3 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
Skytrofa 4.3 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
73362-006 Aug 25, 2021
Skytrofa 5.2 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
Skytrofa 5.2 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
73362-007 Aug 25, 2021
Skytrofa 6.3 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
Skytrofa 6.3 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
73362-008 Aug 25, 2021
Skytrofa 7.6 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
Skytrofa 7.6 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
73362-009 Aug 25, 2021
Skytrofa 9.1 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
Skytrofa 9.1 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
73362-010 Aug 25, 2021
Skytrofa 11 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
Skytrofa 11 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
73362-011 Aug 25, 2021
Skytrofa 13.3 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
Skytrofa 13.3 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Ascendis Pharma Endocrinology, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.